PRETARGETING WITH ANTI-CEA MABS FOR THERAPY

$614,782P01FY2007CANIH

Beckman Research Institute/City Of Hope, Duarte CA

Investigators

Paul Yazakicontact

Linked publications, trials & patents

Paper 32117587 Paper 26556731 Paper 24383763 Paper 24195565 Paper 23638813 Paper 23532891 Paper 23490445 Paper 23175797 Paper 21984873 Paper 21047977 Paper 20802234 Paper 20707718 Paper 20628903 Paper 20554731 Paper 20350626 Paper 19877136 Paper 19647173 Paper 19351765 Paper 19150352 Paper 19010866 Paper 18957406 Paper 18771344 Paper 18720981 Paper 18719907 Paper 18312824 Paper 17988078 Paper 17577599 Paper 17457214 Paper 17379573 Paper 17268029 Paper 17234783 Paper 16882674 Paper 16818514 Paper 16417253 Paper 16370940 Paper 16173788 Paper 16151407 Paper 15994969 Paper 15695407 Paper 15316127 Paper 15297402 Paper 15187222 Paper 14985534 Paper 14970502 Paper 14660722 Paper 12412485 Paper 12236780 Paper 11877757 Paper 11877750 Paper 11809933 Paper 11792185 Paper 11312695 Paper 11312688 Paper 11105590 Paper 10880576 Paper 10841401 Trial NCT01741597 Trial NCT01320683 Trial NCT00738452 Patent 9765155 Patent 9701754 Patent 8940871 Patent 8404817 Patent 8088908 Patent 7776330 Patent 7727525 Patent 7273608 Patent 5844241

View original record on NIH RePORTER →